Characterization and Technical Evaluation of cT1 for NASH (CATE-NASH)

计划入组 28 人 · 首次发布于 2020 年 4 月 10 日

Misoprostol for NASH

计划入组 50 人 · 首次发布于 2023 年 4 月 7 日

Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH

计划入组 26 人 · 首次发布于 2005 年 12 月 21 日

NASH therapeutic

saRNA therapeutics (NASH)

NASH therapy (Lipigon)

Galmed Pharmaceuticals

Israel

Sagimet Biosciences

United States

Inventiva

Prometheus Laboratories Advances Next-Generation Blood Test for MASH Patient Identification

Resmetirom Shows Promise in Treating MASLD/MASH: A Comprehensive Review of Clinical Trials

Semaglutide Shows Superior Efficacy Over Rezdiffra in NASH Resolution and Fibrosis Reduction